About this event:

Date: July 29, 2025

Time: 11 am EDT | 8 am PDT |

5 pm CEST

Duration: 60 minutes

Inherent structural complexity, heterogeneity, and manufacturing sensitivity poses inherent challenges to the development of therapeutic biologics. Recognizing and understanding critical quality attributes (CQAs)—molecular features that affect a biologic’s safety, efficacy, and stability—are essential for ensuring product quality and regulatory compliance.

This webcast shares strategies to study CQAs across diverse modalities, including bispecific and multispecific antibodies, to enable robust quality control.

Attendees can look forward to learning about:

• A systematic analytical toolbox that integrates mass spectrometry, chromatography, and biophysical analysis to decode biologic complexity through CQA identification.
• Strategies to characterize different CQA categories across varied biologic modalities.
• Real-world case studies demonstrating CQA characterization in therapeutic formats.